Hemorrhagic fever viruses are potential agents of bioterrorism by virtue of their ability to cause fever, bleeding, and death after infection. The development of these symptoms has been found to be related to the release of inflammatory cytokines (including IL-6, IL-8, and TNF-alpha). In most systems that have been well studied, the release of inflammatory cytokines is controlled by pattern recognition proteins like CD 14 and Toll like receptor proteins (such as TLR2, TLR3, and TLR4). Lymphocytic Choriomeningitis Virus (LCMV), an arenavirus which causes disease in both humans and mice, is a model for studying the pathogenesis of hemorrhagic fever viruses. Preliminary studies of LCMV, using human and mouse cells indicate that the release of cytokines initiated by LCMV is controlled by CD 14 and TLR2. Toll like receptors, because of their ability to release inflammatory cytokines have a dual role in the response to pathogens. While the acute release of cytokines may cause symptoms (fever, shock, and bleeding) that may be detrimental to the host, these same cytokines may be important in initiating long term immunity. To study the role of CD14 and TLRs, transfected human cells as well knockout mice and cell lines derived from TLR knockout mice will be used. The specific proteins involved in the generation of the immune response will be defined and variant viruses that do not induce an inflammatory cytokine response will be isolated and characterized for their ability to induce long lasting immunity with or without the addition of adjuvants. The role of TLRs in the development of immunity to LCMV mediated by NK cells, B, T cells and antigen presenting cells will be studied. These studies will lead to insights about the pathogenesis of bioterrorist agents as well as new insights into how to treat and prevent arenavirus induced disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
1P01AI057784-01
Application #
6711613
Study Section
Special Emphasis Panel (ZAI1-GB-I (S1))
Project Start
2003-12-01
Project End
2008-11-30
Budget Start
2004-06-01
Budget End
2005-05-31
Support Year
1
Fiscal Year
2004
Total Cost
$356,603
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Rock, Kenneth L (2009) Pathobiology of inflammation to cell death. Biol Blood Marrow Transplant 15:137-8
Wang, Jennifer P; Bowen, Glennice N; Padden, Carolyn et al. (2008) Toll-like receptor-mediated activation of neutrophils by influenza A virus. Blood 112:2028-34
Rock, Kenneth L; Kono, Hajime (2008) The inflammatory response to cell death. Annu Rev Pathol 3:99-126
Kono, Hajime; Rock, Kenneth L (2008) How dying cells alert the immune system to danger. Nat Rev Immunol 8:279-89
Zhou, Shenghua; Halle, Annett; Kurt-Jones, Evelyn A et al. (2008) Lymphocytic choriomeningitis virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses. J Neuroimmunol 194:70-82
Wang, Jennifer P; Kurt-Jones, Evelyn A; Finberg, Robert W (2007) Innate immunity to respiratory viruses. Cell Microbiol 9:1641-6
Finberg, Robert W; Wang, Jennifer P; Kurt-Jones, Evelyn A (2007) Toll like receptors and viruses. Rev Med Virol 17:35-43
Ha, Unhwan; Lim, Jae Hyang; Jono, Hirofumi et al. (2007) A novel role for IkappaB kinase (IKK) alpha and IKKbeta in ERK-dependent up-regulation of MUC5AC mucin transcription by Streptococcus pneumoniae. J Immunol 178:1736-47
Visintin, Alberto; Halmen, Kristen A; Khan, Naseema et al. (2006) MD-2 expression is not required for cell surface targeting of Toll-like receptor 4 (TLR4). J Leukoc Biol 80:1584-92
Mann, Paul B; Wolfe, Daniel; Latz, Eicke et al. (2005) Comparative toll-like receptor 4-mediated innate host defense to Bordetella infection. Infect Immun 73:8144-52